Stefani Wolff - Net Worth and Insider Trading

Stefani Wolff Net Worth

The estimated net worth of Stefani Wolff is at least $2 Million dollars as of 2024-05-15. Stefani Wolff is the Chief Development Officer of Principia Biopharma Inc and owns about 19,096 shares of Principia Biopharma Inc (PRNB) stock worth over $2 Million. Stefani Wolff is also the EVP and COO of Nurix Therapeutics Inc and owns about 6,113 shares of Nurix Therapeutics Inc (NRIX) stock worth over $91,389. Details can be seen in Stefani Wolff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stefani Wolff has not made any transactions after 2023-05-01 and currently still holds the listed stock(s).

Transaction Summary of Stefani Wolff

To

Stefani Wolff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stefani Wolff owns 3 companies in total, including Principia Biopharma Inc (PRNB) , Nurix Therapeutics Inc (NRIX) , and Rain Oncology Inc (RAIN) .

Click here to see the complete history of Stefani Wolff’s form 4 insider trades.

Insider Ownership Summary of Stefani Wolff

Ticker Comapny Transaction Date Type of Owner
PRNB Principia Biopharma Inc 2020-09-28 Chief Development Officer
NRIX Nurix Therapeutics Inc 2023-05-01 EVP and COO
RAIN Rain Oncology Inc 2021-04-22 director

Stefani Wolff Latest Holdings Summary

Stefani Wolff currently owns a total of 2 stocks. Among these stocks, Stefani Wolff owns 19,096 shares of Principia Biopharma Inc (PRNB) as of June 15, 2020, with a value of $2 Million and a weighting of 95.43%. Stefani Wolff also owns 6,113 shares of Nurix Therapeutics Inc (NRIX) as of May 1, 2023, with a value of $91,389 and a weighting of 4.57%.

Latest Holdings of Stefani Wolff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRNB Principia Biopharma Inc 2020-06-15 19,096 100.05 1,910,555
NRIX Nurix Therapeutics Inc 2023-05-01 6,113 14.95 91,389

Holding Weightings of Stefani Wolff


Stefani Wolff Form 4 Trading Tracker

According to the SEC Form 4 filings, Stefani Wolff has made a total of 5 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Principia Biopharma Inc is the sale of 5,504 shares on June 15, 2020, which brought Stefani Wolff around $334,368.

According to the SEC Form 4 filings, Stefani Wolff has made a total of 5 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 342 shares on May 1, 2023, which brought Stefani Wolff around $3,379.

Insider Trading History of Stefani Wolff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stefani Wolff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stefani Wolff Ownership Network

Ownership Network List of Stefani Wolff

No Data

Ownership Network Relation of Stefani Wolff


Stefani Wolff Owned Company Details

What does Principia Biopharma Inc do?

Who are the key executives at Principia Biopharma Inc?

Stefani Wolff is the Chief Development Officer of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Scientific Officer David M Goldstein , and Chief Business Officer Roy C. Hardiman .

Principia Biopharma Inc (PRNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Principia Biopharma Inc Insider Transactions

No Available Data

Stefani Wolff Mailing Address

Above is the net worth, insider trading, and ownership report for Stefani Wolff. You might contact Stefani Wolff via mailing address: C/o Principia Biopharma Inc., 400 East Jamie Court, Suite 302, South San Francisco Ca 94080.

Discussions on Stefani Wolff

No discussions yet.